German Pharma Stock News

XTRA:JUN3
XTRA:JUN3Machinery

Assessing Jungheinrich (XTRA:JUN3) Valuation After Weaker First Quarter Earnings Results

First quarter earnings set the tone for Jungheinrich Jungheinrich (XTRA:JUN3) opened the new financial year with first quarter results showing sales of €1,272 million and net income of €26.2 million, both lower than the same period a year earlier. See our latest analysis for Jungheinrich. The Q1 earnings update has come against a weak share price backdrop, with Jungheinrich’s stock down 29.1% on a year to date share price return and the 1 year total shareholder return also declining 25.7%...
XTRA:EDL
XTRA:EDLEntertainment

European Dividend Stocks To Enhance Your Portfolio

The European market has recently experienced a volatile period, with the pan-European STOXX Europe 600 Index showing modest gains amid easing geopolitical tensions and strong corporate earnings, though tempered by tariff threats from the U.S. In this environment, dividend stocks can be an attractive option for investors seeking steady income streams and potential portfolio enhancement, especially as they offer a measure of stability against market fluctuations.
XTRA:BNR
XTRA:BNRTrade Distributors

Brenntag (XTRA:BNR) Margin Compression And One Off Loss Test Bullish Narratives In Q1 2026

Q1 2026 earnings snapshot and what it means for Brenntag (XTRA:BNR) Brenntag (XTRA:BNR) opened 2026 with Q1 revenue of €3.7b and basic EPS of €0.68, setting a fresh reference point for investors lining up the latest numbers against a share price of €61.64. Over recent quarters the company has seen revenue move from €4.1b in Q1 2025 to €3.9b in Q4 2025 and then to €3.7b in Q1 2026, while quarterly basic EPS shifted from €0.93 to a loss of €0.20 and then to €0.68. With trailing net profit...
XTRA:MRK
XTRA:MRKPharmaceuticals

Merck KGaA (XTRA:MRK) Margin Decline Challenges Bullish Profit Expansion Narrative

Merck KGaA (XTRA:MRK) has reported Q1 2026 revenue of €5.1b and basic EPS of €1.52, with the trailing twelve month figures sitting at €21.0b of revenue and EPS of €5.83. Over recent quarters, revenue has moved from €5.28b in Q1 2025 to €5.25b in Q2 2025, €5.32b in Q3 2025 and €5.25b in Q4 2025, while EPS shifted from €1.69 to €1.50, €2.07 and €0.73 across the same periods. This gives investors a clearer view of how the top and bottom line have tracked into this latest print. With a net profit...
XTRA:RWE
XTRA:RWERenewable Energy

RWE (XTRA:RWE) Q1 EPS Collapse Tests Long‑Term Renewables Growth Narrative

RWE (XTRA:RWE) opened 2026 with Q1 revenue of €4.3b and net income of €20m, translating to basic EPS of €0.03, against a trailing twelve month EPS of €3.27 on revenue of €16.3b and net income of €2.4b. The company has seen quarterly revenue move from €6.4b in Q1 2025 to €4.3b in Q1 2026, while basic EPS shifted from €1.07 to €0.03 over the same period. Trailing margins settled at a net profit level of 14.5%, setting up this result as a test of how much short term earnings softness investors...
XTRA:UN0
XTRA:UN0Renewable Energy

Uniper (XTRA:UN0) Valuation Check As Profitability Jumps Following Latest Earnings Release

Why Uniper’s latest earnings matter for shareholders Uniper (XTRA:UN0) just released first quarter 2026 results, with sales of €17,414 million compared with €21,341 million a year earlier, while net income moved to €335 million from €85 million. Basic earnings per share from continuing operations came in at €0.8 compared with €0.2 a year ago, putting profitability at the center of the current discussion around the stock. See our latest analysis for Uniper. At a share price of €43.75, Uniper’s...
XTRA:LEG
XTRA:LEGReal Estate

LEG Immobilien (XTRA:LEG) Q1 2026 EPS Drop Reinforces Bearish Earnings Narratives

LEG Immobilien (XTRA:LEG) has opened Q1 2026 with total revenue of €367.7 million and basic EPS of €1.03, giving investors a fresh datapoint after a year of very large earnings swings that were heavily influenced by one off items. The company has seen quarterly revenue move from €515.9 million in Q4 2024 to a range between €351.4 million and €468.7 million across 2025, while basic EPS shifted between €0.81 and €9.08 over the same period. This underscores just how volatile the income line has...
XTRA:AFX
XTRA:AFXMedical Equipment

Carl Zeiss Meditec (XTRA:AFX) Margin Compression To 4.4% Tests Bullish Earnings Recovery Narrative

Carl Zeiss Meditec (XTRA:AFX) has just posted its Q2 2026 numbers, with revenue at €524.0 million and basic EPS of €0.22, setting the tone for how investors might read the latest quarter. Over recent periods, revenue has moved between €560.0 million in Q2 2025 and €524.0 million in Q2 2026, while EPS has ranged from €0.52 in Q2 2025 to €0.22 in the latest quarter. This gives a clearer view of how the top line and per share earnings have tracked into this result. With trailing net profit...
XTRA:BAS
XTRA:BASChemicals

BASF’s BioHub, Polymer Focus And Farm Safety Efforts Underpin Valuation Debate

BASF has commissioned a new fermentation plant at its BioHub facility for biological crop protection products. The company is highlighting its role in the Super Absorbent Polymer market, with a focus on sustainability driven applications. BASF is expanding its Safety Scouts farm safety education program as part of wider community engagement efforts. BASF (XTRA:BAS) is drawing attention for operational moves that sit outside headline earnings, from commissioning its BioHub fermentation plant...
XTRA:TKA
XTRA:TKAMetals and Mining

A Look At Thyssenkrupp (XTRA:TKA) Valuation After Recent Share Price Momentum And Undervalued Narrative

thyssenkrupp (XTRA:TKA) has drawn investor attention after its latest reported figures highlighted annual revenue of €31,993.0 million and net income of €9.0 million. This has prompted a closer look at how the stock has been trading recently. See our latest analysis for thyssenkrupp. At a latest share price of €10.41, thyssenkrupp’s 1 day share price return of 5.15% and 30 day share price return of 24.05% suggest momentum has picked up recently. The 1 year total shareholder return of 48.91%...
XTRA:DEZ
XTRA:DEZMachinery

3 European Stocks That May Be Trading Below Their Estimated Value

The European market has recently seen modest gains, with the pan-European STOXX Europe 600 Index benefiting from easing geopolitical tensions and robust corporate earnings, although concerns about potential U.S. tariffs have tempered investor enthusiasm. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank’s Valuation After Recent Bond Issuances And Expanded Fixed Income Funding Activity

Why Deutsche Bank’s latest bond activity has caught investors’ attention Deutsche Bank (XTRA:DBK) has been active in May 2026, issuing and completing multiple fixed income offerings, including new senior unsecured notes with maturities stretching out to 2046 and a range of fixed coupons. This funding activity gives you a fresh data point on how the bank is raising long term capital, what kind of coupons it is willing to pay, and how its balance sheet mix between debt and equity might evolve...
XTRA:AG1
XTRA:AG1Specialty Retail

AUTO1 Group (XTRA:AG1) Valuation Check As Record Unit Growth And Cash Position Support Investor Optimism

Earnings context and what just changed AUTO1 Group (XTRA:AG1) has drawn investor attention after reporting first quarter 2026 results, with sales of €2,437.14 million and net income of €26.15 million, alongside record units sold and gross profit. See our latest analysis for AUTO1 Group. The first quarter update arrived alongside a sharp swing in sentiment, with a 1-day share price return of 12.90% and a 7-day share price return of 11.37%, even though the year to date share price return is...
XTRA:PUM
XTRA:PUMLuxury

PUMA (XTRA:PUM) Valuation Check As New CFO Appointment Follows Latest Quarterly Earnings

PUMA (XTRA:PUM) is back in focus after appointing Mark Langer as Chief Financial Officer alongside releasing first quarter 2026 results. This combination gives investors fresh information on both leadership and earnings. See our latest analysis for PUMA. The recent CFO appointment and first quarter 2026 results come against a backdrop of improving share price momentum, with a 1 day share price return of 4.80%, a 90 day share price return of 11.63% and a 1 year total shareholder return of...
XTRA:HAG
XTRA:HAGAerospace & Defense

A Look At Hensoldt’s (XTRA:HAG) Valuation After First Quarter 2026 Earnings Update

Why Hensoldt’s latest earnings matter for shareholders Hensoldt (XTRA:HAG) reported first quarter 2026 earnings with sales of €496 million, compared with €395 million a year earlier. The net loss improved to €19 million and basic loss per share to €0.16. See our latest analysis for Hensoldt. The first quarter update appears to have shifted sentiment in the short term, with a 1-day share price return of 3.95% to €74.3, even though the 90-day share price return is down 6.01% and the 5-year...
XTRA:ADS
XTRA:ADSLuxury

Assessing Adidas (XTRA:ADS) Valuation After Its New World Cup Backyard Legends Campaign

Adidas (XTRA:ADS) is back in the World Cup spotlight, unveiling its “Backyard Legends” campaign that digitally de ages Zidane, Beckham and Del Piero alongside Timothée Chalamet, Bad Bunny and Lionel Messi. See our latest analysis for adidas. The new World Cup campaign lands at a time when the stock’s 30 day share price return of 5.88% contrasts with a year to date decline of 13.98%. The 1 year total shareholder return is down 33.85%, pointing to near term momentum after a tougher longer term...
XTRA:HLAG
XTRA:HLAGShipping

Hapag-Lloyd (XTRA:HLAG) Valuation After Q1 2026 Loss And ZIM Merger Approval

What Hapag-Lloyd’s latest quarterly loss means for shareholders Hapag-Lloyd (XTRA:HLAG) just posted first quarter 2026 earnings that showed sales of €4,200.9m and a shift from prior year profit to a net loss of €220.3m, putting the stock firmly back in focus. See our latest analysis for Hapag-Lloyd. At a share price of €117.6, Hapag-Lloyd’s recent earnings loss and the approved merger agreement with ZIM have come against a backdrop of fairly muted share price moves over shorter periods and a...